mySugr Overview
Pro stress-test →Founded in 2012 and acquired by Roche in 2017, mySugr is a digital health company that simplifies life with diabetes through technology and support services. The mySugr App integrates with medical devices to empower people with diabetes through comprehensive self-management including a logbook, insulin calculator, diabetes coach, and doctor reports.
Strategic Profile
Pro stress-test →The platform serves over 5 million people with diabetes across more than 80 countries, positioning mySugr as a global digital diabetes leader. As part of Roche's portfolio, mySugr operates from Vienna alongside other Roche diabetes care solutions including Accu-Chek and navify. Maintaining an open platform architecture, mySugr allows users to upload blood glucose data from any device into its logbook application.
Competitive Landscape
Pro stress-test →mySugr competes in the digital diabetes management space with subscription-based and standalone app platforms. Key competitors include Omada Health (wellness platform with diabetes focus), One Drop (subscription blood glucose monitoring), and Virta Health (specialty diabetes clinic). Dexcom and Medtronic operate as device partners, while traditional pharmaceutical players (Merck, CVS Health) and tech entrants (Apple) are exploring adjacent diabetes management services.
Industry Context
mySugr operates in Digital diabetes management platforms.
Key facts
Founded: 2012 · Headquarters: Vienna, Austria · Revenue: N/A · Market cap: N/A